Back
Celldex Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
37
CLDX
Celldex Therapeutics, Inc.
Last Price:
$27.27
Seasonality Move:
15.7%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CLDX is experiencing slight buying pressure.
Celldex Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 26.75 | Sell |
| 20-day SMA: | 27.19 | Sell |
| 50-day SMA: | 26.28 | Sell |
| 200-day SMA: | 22.65 | Buy |
| 8-day EMA: | 26.48 | Sell |
| 20-day EMA: | 26.75 | Sell |
| 50-day EMA: | 26.21 | Sell |
| 200-day EMA: | 24.85 | Buy |
Celldex Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.06 | Buy |
| Relative Strength Index (14 RSI): | 43.26 | Sell |
| Chaikin Money Flow: | 115250 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (25.47 - 28.21) | Sell |
| Bollinger Bands (100): | (23.01 - 27.19) | Buy |
Celldex Therapeutics, Inc. Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Celldex Therapeutics, Inc. Stock
Is Celldex Therapeutics, Inc. Stock a Buy?
-
Celldex Therapeutics, Inc. share price is 25.60 while CLDX 8-day simple moving average is 26.75, which is a Sell signal.
-
The stock price of CLDX is 25.60 while Celldex Therapeutics, Inc. 20-day SMA is 27.19, which makes it a Sell.
-
Celldex Therapeutics, Inc. 50-day simple moving average is 26.28 while CLDX share price is 25.60, making it a Sell technically.
-
CLDX stock price is 25.60 and Celldex Therapeutics, Inc. 200-day simple moving average is 22.65, creating a Buy signal.
CLDX Technical Analysis vs Fundamental Analysis
Sell
37
Celldex Therapeutics, Inc. (CLDX)
is a Sell
Is Celldex Therapeutics, Inc. a Buy or a Sell?
-
Celldex Therapeutics, Inc. stock is rated a SellThe current Celldex Therapeutics, Inc. [CLDX] share price is $25.60. The Score for CLDX is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
Celldex Therapeutics, Inc. Stock Info
Market Cap:
1.7B
Price in USD:
25.60
Share Volume:
1.6M
Celldex Therapeutics, Inc. 52-Week Range
52-Week High:
30.50
52-Week Low:
14.40
Sell
37
Celldex Therapeutics, Inc. (CLDX)
is a Sell
Celldex Therapeutics, Inc. Share Price Forecast
-
What is the Celldex Therapeutics, Inc. stock price today?The Celldex Therapeutics, Inc. stock price is 25.60 USD today.
-
Will CLDX stock go up or go down?Celldex Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Celldex Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Celldex Therapeutics, Inc. is overvalued.
Is Celldex Therapeutics, Inc. Stock a Buy?
-
Celldex Therapeutics, Inc. share price is 25.60 while CLDX 8-day exponential moving average is 26.48, which is a Sell signal.
-
The stock price of CLDX is 25.60 while Celldex Therapeutics, Inc. 20-day EMA is 26.75, which makes it a Sell.
-
Celldex Therapeutics, Inc. 50-day exponential moving average is 26.21 while CLDX share price is 25.60, making it a Sell technically.
-
CLDX stock price is 25.60 and Celldex Therapeutics, Inc. 200-day simple moving average is 24.85, creating a Buy signal.
Fundamental Analysis of Celldex Therapeutics, Inc.
Is Celldex Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.22 per share, and a decrease next year of $0.83 per share.
Technical Analysis of Celldex Therapeutics, Inc.
Should I short Celldex Therapeutics, Inc. stock?
-
CLDX Moving Average Covergence Divergence (MACD) indicator is 0.06, suggesting Celldex Therapeutics, Inc. is a Buy
-
Celldex Therapeutics, Inc. Relative Strength Index (RSI) is 43.26, which suggest Celldex Therapeutics, Inc. is oversold
-
The Bollinger Bands (25) for Celldex Therapeutics, Inc. is (25.47 - 28.21), which suggest Celldex Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Celldex Therapeutics, Inc. is (23.01 - 27.19), which suggest Celldex Therapeutics, Inc. is a Buy
* Celldex Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.